EGFR inhibitor-resistant lung cancers exhibit collateral sensitivity to a covalent, cysteine-independent KEAP1 oligomerizing molecular bridge

Journal:

Nature Communications

Published:

2026-01-14

DOI:

10.1038/s41467-026-68424-1

Affiliations:

9

Authors:

31

Go to article

Institutions	Authors	Share
Duke University, United States of America (USA)	17.000000 17.000000	0.55
Mediterranean Centre for Molecular Medicine (C3M), France	3.000000	0.10
Weizmann Institute of Science (WIS), Israel	3.000000	0.10
Massachusetts General Hospital (MGH), United States of America (USA)	2.000000	0.06
Baylor College of Medicine (BCM), United States of America (USA)	2.000000	0.06
Institute of Chemistry of Nice (ICN), France	2.000000	0.06
Institut de Recherche Saint-Louis (IRSL), France	1.000000	0.03
Mohammed VI Polytechnic University, Morocco	0.500000	0.02
Institute of Biomolecules Max Mousseron (IBMM), France	0.500000	0.02

Interested in Oncology and Carcinogenesis?